Marco Tampellini
Turin, 10098, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Infections in lung cancer patients undergoing immunotherapy and targeted therapy: An overview on the current scenario.
Journal: Critical reviews in oncology/hematology
Published: January 21, 2023
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.
Journal: International journal of cancer
Published: March 28, 2022
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: October 08, 2020
Impact of early tumor shrinkage and depth of response on the outcomes of panitumumab-based maintenance in patients with RAS wild-type metastatic colorectal cancer.
Journal: European journal of cancer (Oxford, England : 1990)
Published: August 20, 2020
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Journal: British journal of cancer
Published: January 25, 2020
Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 19, 2019
Maintenance Therapy With Panitumumab Alone vs Panitumumab Plus Fluorouracil-Leucovorin in Patients With RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
Journal: JAMA oncology
Published: July 04, 2019
The Circadian Rhythm of Breakthrough Pain Episodes in Terminally-ill Cancer Patients.
Journal: Cancers
Published: November 16, 2018
Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment?
Journal: Future oncology (London, England)
Published: April 28, 2018
Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 19, 2017
Last Updated: 09/26/2026